nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—multiple sclerosis	0.672	1	CbGaD
Clenbuterol—NGF—sciatic nerve—multiple sclerosis	0.0457	0.352	CbGeAlD
Clenbuterol—NGF—trigeminal nerve—multiple sclerosis	0.0374	0.288	CbGeAlD
Clenbuterol—NGF—peripheral nervous system—multiple sclerosis	0.0175	0.135	CbGeAlD
Clenbuterol—NGF—nerve—multiple sclerosis	0.0137	0.105	CbGeAlD
Clenbuterol—NGF—spinal cord—multiple sclerosis	0.00365	0.0281	CbGeAlD
Clenbuterol—Bambuterol—BCHE—multiple sclerosis	0.00337	0.618	CrCbGaD
Clenbuterol—NGF—nervous system—multiple sclerosis	0.00307	0.0237	CbGeAlD
Clenbuterol—NGF—central nervous system—multiple sclerosis	0.00296	0.0228	CbGeAlD
Clenbuterol—NGF—brain—multiple sclerosis	0.00235	0.0181	CbGeAlD
Clenbuterol—Terbutaline—BCHE—multiple sclerosis	0.00208	0.382	CrCbGaD
Clenbuterol—ADRB1—nervous system—multiple sclerosis	0.0008	0.00616	CbGeAlD
Clenbuterol—ADRB1—central nervous system—multiple sclerosis	0.00077	0.00593	CbGeAlD
Clenbuterol—ADRB1—brain—multiple sclerosis	0.000612	0.00471	CbGeAlD
Clenbuterol—CYP1A1—nervous system—multiple sclerosis	0.000516	0.00397	CbGeAlD
Clenbuterol—CYP1A1—central nervous system—multiple sclerosis	0.000497	0.00382	CbGeAlD
Clenbuterol—CYP1A1—brain—multiple sclerosis	0.000394	0.00304	CbGeAlD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL6—multiple sclerosis	6.29e-05	0.000327	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.28e-05	0.000326	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL10—multiple sclerosis	6.26e-05	0.000325	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCL2—multiple sclerosis	6.25e-05	0.000324	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	6.23e-05	0.000323	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LINGO1—multiple sclerosis	6.2e-05	0.000322	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL10—multiple sclerosis	6.18e-05	0.000321	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL10—multiple sclerosis	6.12e-05	0.000318	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CNR1—multiple sclerosis	6.01e-05	0.000312	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR1—multiple sclerosis	6e-05	0.000311	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL13—multiple sclerosis	6e-05	0.000311	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR1—multiple sclerosis	5.97e-05	0.00031	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL13—multiple sclerosis	5.97e-05	0.00031	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL10—multiple sclerosis	5.96e-05	0.000309	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	5.87e-05	0.000304	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR1—multiple sclerosis	5.87e-05	0.000304	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.7e-05	0.000296	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.7e-05	0.000296	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SRM—multiple sclerosis	5.65e-05	0.000293	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—MYC—multiple sclerosis	5.62e-05	0.000291	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFB1—multiple sclerosis	5.6e-05	0.000291	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL6—multiple sclerosis	5.6e-05	0.000291	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.54e-05	0.000287	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.53e-05	0.000287	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	5.5e-05	0.000285	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—MAPK1—multiple sclerosis	5.49e-05	0.000285	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.42e-05	0.000281	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL10—multiple sclerosis	5.41e-05	0.000281	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CD86—multiple sclerosis	5.4e-05	0.00028	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	5.39e-05	0.000279	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	5.38e-05	0.000279	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCL5—multiple sclerosis	5.32e-05	0.000276	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	5.27e-05	0.000273	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—POMC—multiple sclerosis	5.23e-05	0.000272	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—IL6—multiple sclerosis	5.18e-05	0.000269	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.16e-05	0.000268	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.16e-05	0.000268	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCL5—multiple sclerosis	5.13e-05	0.000266	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.07e-05	0.000263	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.06e-05	0.000262	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.98e-05	0.000258	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.96e-05	0.000257	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SPP1—multiple sclerosis	4.92e-05	0.000256	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	4.91e-05	0.000255	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.87e-05	0.000253	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.87e-05	0.000253	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	4.85e-05	0.000252	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	4.81e-05	0.000249	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCR5—multiple sclerosis	4.79e-05	0.000249	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.77e-05	0.000247	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	4.75e-05	0.000246	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL2RA—multiple sclerosis	4.72e-05	0.000245	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	4.7e-05	0.000244	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	4.67e-05	0.000243	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCL5—multiple sclerosis	4.66e-05	0.000242	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR5—multiple sclerosis	4.62e-05	0.00024	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	4.57e-05	0.000237	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2RA—multiple sclerosis	4.55e-05	0.000236	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	4.53e-05	0.000235	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.48e-05	0.000232	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	4.43e-05	0.00023	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	4.37e-05	0.000227	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—APOE—multiple sclerosis	4.36e-05	0.000226	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	4.28e-05	0.000222	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	4.27e-05	0.000222	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	4.26e-05	0.000221	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL3—multiple sclerosis	4.25e-05	0.000221	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR5—multiple sclerosis	4.2e-05	0.000218	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	4.18e-05	0.000217	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	4.16e-05	0.000216	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2RA—multiple sclerosis	4.13e-05	0.000215	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	4.11e-05	0.000213	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTGER4—multiple sclerosis	4.09e-05	0.000212	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	4.09e-05	0.000212	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PGR—multiple sclerosis	4.03e-05	0.000209	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	4.02e-05	0.000209	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	4e-05	0.000207	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	3.98e-05	0.000206	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	3.98e-05	0.000206	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	3.97e-05	0.000206	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCR3—multiple sclerosis	3.95e-05	0.000205	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CD80—multiple sclerosis	3.94e-05	0.000204	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	3.93e-05	0.000204	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CD28—multiple sclerosis	3.92e-05	0.000203	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.89e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	3.89e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	3.87e-05	0.000201	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	3.86e-05	0.000201	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR2—multiple sclerosis	3.85e-05	0.0002	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	3.84e-05	0.000199	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	3.79e-05	0.000197	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	3.79e-05	0.000197	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	3.78e-05	0.000196	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—POMC—multiple sclerosis	3.74e-05	0.000194	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	3.71e-05	0.000193	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	3.71e-05	0.000192	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCL2—multiple sclerosis	3.66e-05	0.00019	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TYK2—multiple sclerosis	3.64e-05	0.000189	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GPC5—multiple sclerosis	3.64e-05	0.000189	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	3.63e-05	0.000188	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—POMC—multiple sclerosis	3.61e-05	0.000187	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SRM—multiple sclerosis	3.6e-05	0.000187	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	3.57e-05	0.000185	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CNR1—multiple sclerosis	3.55e-05	0.000184	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	3.54e-05	0.000184	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	3.54e-05	0.000184	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	3.54e-05	0.000183	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	3.49e-05	0.000181	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	3.47e-05	0.00018	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	3.47e-05	0.00018	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.46e-05	0.000179	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.34e-05	0.000173	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TYK2—multiple sclerosis	3.33e-05	0.000173	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—POMC—multiple sclerosis	3.28e-05	0.00017	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	3.21e-05	0.000167	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCL2—multiple sclerosis	3.21e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL10—multiple sclerosis	3.2e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	3.14e-05	0.000163	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	3.04e-05	0.000158	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—RRM1—multiple sclerosis	3.01e-05	0.000156	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	2.98e-05	0.000154	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—TYK2—multiple sclerosis	2.91e-05	0.000151	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—multiple sclerosis	2.87e-05	0.000149	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CD86—multiple sclerosis	2.79e-05	0.000145	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL2—multiple sclerosis	2.77e-05	0.000144	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	2.76e-05	0.000143	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL5—multiple sclerosis	2.75e-05	0.000143	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	2.74e-05	0.000142	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	2.7e-05	0.00014	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.7e-05	0.00014	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	2.68e-05	0.000139	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2—multiple sclerosis	2.67e-05	0.000139	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.64e-05	0.000137	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—multiple sclerosis	2.62e-05	0.000136	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—STAT3—multiple sclerosis	2.55e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SPP1—multiple sclerosis	2.55e-05	0.000132	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.54e-05	0.000132	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.54e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	2.52e-05	0.000131	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	2.49e-05	0.000129	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.48e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR5—multiple sclerosis	2.48e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	2.47e-05	0.000128	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	2.45e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2RA—multiple sclerosis	2.44e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	2.44e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	2.43e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2—multiple sclerosis	2.42e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	2.4e-05	0.000125	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	2.39e-05	0.000124	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	2.38e-05	0.000123	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—multiple sclerosis	2.36e-05	0.000123	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	2.35e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	2.34e-05	0.000121	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.34e-05	0.000121	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—STAT3—multiple sclerosis	2.33e-05	0.000121	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	2.32e-05	0.000121	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.32e-05	0.00012	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MAPK1—multiple sclerosis	2.32e-05	0.00012	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	2.3e-05	0.000119	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	2.28e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	2.27e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOE—multiple sclerosis	2.25e-05	0.000117	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	2.23e-05	0.000116	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MYC—multiple sclerosis	2.16e-05	0.000112	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—multiple sclerosis	2.16e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	2.14e-05	0.000111	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAPK1—multiple sclerosis	2.12e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	2.11e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	2.1e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	2.06e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CD80—multiple sclerosis	2.04e-05	0.000106	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.01e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	1.95e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—POMC—multiple sclerosis	1.94e-05	0.000101	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.92e-05	9.97e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	1.9e-05	9.88e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	1.9e-05	9.88e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	1.9e-05	9.84e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL2—multiple sclerosis	1.9e-05	9.83e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	1.86e-05	9.67e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	1.86e-05	9.63e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—MAPK1—multiple sclerosis	1.85e-05	9.62e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.83e-05	9.51e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—multiple sclerosis	1.78e-05	9.24e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.73e-05	8.99e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	1.73e-05	8.97e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TYK2—multiple sclerosis	1.72e-05	8.93e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	1.69e-05	8.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	1.66e-05	8.61e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	1.63e-05	8.47e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—multiple sclerosis	1.63e-05	8.44e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	1.62e-05	8.42e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	1.6e-05	8.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	1.58e-05	8.22e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	1.55e-05	8.04e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	1.51e-05	7.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.49e-05	7.74e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	1.48e-05	7.68e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	1.47e-05	7.63e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	1.45e-05	7.52e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	1.44e-05	7.47e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	1.44e-05	7.47e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—multiple sclerosis	1.43e-05	7.43e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—multiple sclerosis	1.42e-05	7.39e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	1.42e-05	7.36e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	1.41e-05	7.3e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—multiple sclerosis	1.36e-05	7.03e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	1.34e-05	6.94e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	1.31e-05	6.79e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.28e-05	6.65e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	1.21e-05	6.28e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STAT3—multiple sclerosis	1.2e-05	6.25e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	1.18e-05	6.14e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.17e-05	6.06e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	1.15e-05	5.97e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	1.12e-05	5.84e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	1.12e-05	5.84e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—multiple sclerosis	1.12e-05	5.81e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—multiple sclerosis	1.12e-05	5.8e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.1e-05	5.73e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	1.1e-05	5.71e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	1.1e-05	5.71e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK1—multiple sclerosis	1.1e-05	5.68e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	1.08e-05	5.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOE—multiple sclerosis	1.04e-05	5.41e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	1.02e-05	5.3e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	9.99e-06	5.18e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—POMC—multiple sclerosis	8.95e-06	4.64e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	8.5e-06	4.41e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	8.46e-06	4.39e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—multiple sclerosis	8.42e-06	4.37e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	8.31e-06	4.31e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	8.27e-06	4.29e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—multiple sclerosis	8.16e-06	4.23e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	8.04e-06	4.17e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	7.87e-06	4.08e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	7.15e-06	3.71e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	7e-06	3.63e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	6.65e-06	3.45e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOE—multiple sclerosis	6.64e-06	3.45e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	6.63e-06	3.44e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	6.5e-06	3.37e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	6.5e-06	3.37e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	6.49e-06	3.37e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	6.36e-06	3.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—POMC—multiple sclerosis	5.71e-06	2.96e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—multiple sclerosis	5.2e-06	2.7e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	5e-06	2.59e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	4.89e-06	2.54e-05	CbGpPWpGaD
